
Immunic, Inc.
IMUXHealthcare|Biotechnology|US
$7.75
+0.43 (+5.87%)
DCF Value
$0.60
Tangible Book / Share
$3.00
Cash / Share
$3.65
Ownership Breakdown
88.0%
Float
13.6M
Shares Outstanding
12.0M
Float Shares
Major Holders (40)
Combined: 358.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | Partnership | 9.99% | 29,126,906 | Feb 20, 2026 | 13D/G |
| Lampert Mark N | Individual | 9.99% | 13,630,601 | Feb 20, 2026 | 13D/G |
| BVF Partners L P/Il | IA, PN | 9.99% | 13,630,601 | Feb 20, 2026 | 13D/G |
| BVF Inc/Il | Corporation | 9.99% | 13,630,601 | Feb 20, 2026 | 13D/G |
| Vivo Opportunity Cayman, LLC | Other | 9.99% | 2,942,094 | Feb 20, 2026 | 13D/G |
| Vivo Opportunity Cayman Fund, L.P. | Partnership | 9.99% | 2,942,094 | Feb 20, 2026 | 13D/G |
| Vivo Opportunity, LLC | Other | 9.99% | 29,126,906 | Feb 20, 2026 | 13D/G |
| Janus Henderson Group PLC | IA, HC | 9.99% | 12,016,444 | Dec 8, 2025 | 13D/G |
| Adage Capital Management, L.P. | IA, PN | 9.99% | 10,479,337 | Aug 12, 2025 | 13D/G |
| Phillip Gross | HC, IN | 9.99% | 10,479,337 | Aug 12, 2025 | 13D/G |
| Robert Atchinson | HC, IN | 9.99% | 10,479,337 | Aug 12, 2025 | 13D/G |
| Michael Kramarz | HC, IN | 9.90% | 1,511,821 | Aug 14, 2026 | 13D/G |
| Robert Egen Atkinson | HC, IN | 9.90% | 1,511,821 | Aug 14, 2026 | 13D/G |
| Commodore Capital LP | IA, PN | 9.90% | 1,511,821 | Aug 14, 2026 | 13D/G |
| Commodore Capital Master LP | Partnership | 9.90% | 1,511,821 | Aug 14, 2026 | 13D/G |
| Avidity Private Master Fund I LP | Partnership | 9.90% | 13,958,410 | Apr 17, 2026 | 13D/G |
| Michael Gregory | HC, IN | 9.90% | 13,958,410 | Apr 17, 2026 | 13D/G |
| Avidity Capital Partners (GP) LLC | Other | 9.90% | 13,958,410 | Apr 17, 2026 | 13D/G |
| Avidity Capital Partners Fund (GP) LP | Partnership | 9.90% | 13,958,410 | Apr 17, 2026 | 13D/G |
| Avidity Partners Management (GP) LLC | Other | 9.90% | 13,958,410 | Apr 17, 2026 | 13D/G |
| Avidity Partners Management LP | IA, PN | 9.90% | 13,958,410 | Apr 17, 2026 | 13D/G |
| BVF GP Holdings LLC | Other | 9.60% | 13,140,690 | Feb 20, 2026 | 13D/G |
| Ortav Yehudai | Individual | 8.70% | 11,454,000 | Feb 24, 2026 | 13D/G |
| Trails Edge Biotechnology Master Fund, LP | Partnership | 8.70% | 11,454,000 | Feb 24, 2026 | 13D/G |
| Trails Edge Capital Partners, LP | IA, PN | 8.70% | 11,454,000 | Feb 24, 2026 | 13D/G |
| David Kroin | HC, IN | 8.69% | 11,454,000 | Mar 4, 2026 | 13D/G |
| Deep Track Capital, LP | IA, OO | 8.69% | 11,454,000 | Mar 4, 2026 | 13D/G |
| abrdn Inc | IA, CO | 8.60% | 8,243,941 | Jul 31, 2025 | 13D/G |
| abrdn Inc. | IA, CO | 7.99% | 1,090,427 | Nov 2, 2026 | 13D/G |
| Aberdeen Group plc | Holding company | 7.99% | 1,090,427 | Nov 2, 2026 | 13D/G |
| Daniel Mack | Holding company | 7.47% | 1,079,843 | Aug 14, 2026 | 13D/G |
| Nantahala Capital Management, LLC | Investment adviser | 7.47% | 1,079,843 | Aug 14, 2026 | 13D/G |
| Wilmot B. Harkey | Holding company | 7.47% | 1,079,843 | Aug 14, 2026 | 13D/G |
| Biotechnology Value Fund L P | Partnership | 7.40% | 10,113,585 | Feb 20, 2026 | 13D/G |
| BVF I GP LLC | Other | 7.40% | 10,113,585 | Feb 20, 2026 | 13D/G |
| Israel A. Englander | Individual | 7.00% | 969,547 | Aug 6, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 7.00% | 969,547 | Aug 6, 2026 | 13D/G |
| Millennium Management LLC | Other | 7.00% | 969,547 | Aug 6, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 6.90% | 960,816 | Aug 6, 2026 | 13D/G |
| Deep Track Biotechnology Master Fund, Ltd. | Corporation | 6.79% | 8,953,630 | Mar 4, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 8,968,920 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nagel Robert Thorvald | director | Sep 16, 2026 | AWARD | 25,370 | $10.12 | $256.7K | Form 4 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | Sep 16, 2026 | AWARD | 25,370 | $10.12 | $256.7K | Form 4 |
| Ridloff Elena | director | Aug 6, 2026 | AWARD | 50,740 | $14.54 | $737.8K | Form 4 |
| Ridloff Elena | director: | Aug 6, 2026 | OTHER | 0 | — | — | Form 4 |
| Skerjanec Simona | director | Jul 5, 2026 | AWARD | 25,370 | $14.80 | $375.5K | Form 4 |
| Rudick Richard Alan | director | Jul 5, 2026 | AWARD | 25,370 | $14.80 | $375.5K | Form 4 |
| PHILLIPS BARCLAY A | director | Jul 5, 2026 | AWARD | 25,370 | $14.80 | $375.5K | Form 4 |
| Neermann Joerg | director | Jul 5, 2026 | AWARD | 25,370 | $14.80 | $375.5K | Form 4 |
| Congleton Jon | director | Jul 5, 2026 | AWARD | 25,370 | $14.80 | $375.5K | Form 4 |
| Congleton Jon | director | Jun 29, 2026 | AWARD | 50,740 | $10.90 | $553.1K | Form 4 |
| Skerjanec Simona | director | Jun 29, 2026 | AWARD | 25,370 | $10.90 | $276.5K | Form 4 |
| Rudick Richard Alan | director | Jun 29, 2026 | AWARD | 25,370 | $10.90 | $276.5K | Form 4 |
| HOWSON TAMAR D | director | Jun 29, 2026 | AWARD | 25,370 | $10.90 | $276.5K | Form 4 |
| Neermann Joerg | director | Jun 29, 2026 | AWARD | 25,370 | $10.90 | $276.5K | Form 4 |
| PHILLIPS BARCLAY A | director | Jun 29, 2026 | AWARD | 25,370 | $10.90 | $276.5K | Form 4 |
| Tardio Jason | President and COO | Jun 29, 2026 | AWARD | 253,000 | $11.60 | $2.9M | Form 4 |
| Whaley Glenn | Chief Financial Officer | Jun 29, 2026 | AWARD | 120,000 | $11.60 | $1.4M | Form 4 |
| Vitt Daniel | director | Jun 29, 2026 | AWARD | 445,000 | $11.60 | $5.2M | Form 4 |
| BONNEY MICHAEL W | director | Jun 29, 2026 | AWARD | 100,000 | $12.08 | $1.2M | Form 4 |
| Lundgren Erik | Chief Executive Officer | May 22, 2026 | AWARD | 1,000,000 | $13.05 | $13.1M | Form 4 |
| Lundgren Erik | officer | Jun 1, 2026 | OTHER | 0 | — | — | Form 4 |
| BONNEY MICHAEL W | director: | May 16, 2026 | OTHER | 0 | — | — | Form 4 |
| Panzara Michael A. | Chief Medical Officer | Apr 24, 2026 | AWARD | 300,000 | $8.80 | $2.6M | Form 4 |
| Panzara Michael A. | officer | Apr 24, 2026 | OTHER | 0 | — | — | Form 4 |
| Congleton Jon | director: | Mar 27, 2026 | OTHER | 0 | — | — | Form 4 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | Feb 17, 2026 | OTHER | 0 | — | — | Form 4 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | Feb 17, 2026 | OTHER | 0 | — | — | Form 4 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | Feb 17, 2026 | OTHER | 0 | — | — | Form 4 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | Feb 17, 2026 | OTHER | 3,202,262 | — | — | Form 4 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | Feb 17, 2026 | OTHER | 3,202,262 | — | — | Form 4 |
| Nagel Robert Thorvald | director: | Feb 17, 2026 | OTHER | 0 | — | — | Form 4 |
| Whaley Glenn | Chief Financial Officer | Jul 16, 2025 | AWARD | 560,000 | $0.77 | $431.2K | Form 4 |
| Whaley Glenn | Chief Financial Officer | Jul 16, 2025 | AWARD | 280,000 | $0.77 | $215.6K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Jul 16, 2025 | AWARD | 630,000 | $0.77 | $485.1K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Jul 16, 2025 | AWARD | 315,000 | $0.77 | $242.6K | Form 4 |
| Vitt Daniel | director, officer: CEO and Director | Jul 16, 2025 | AWARD | 1,720,000 | $0.77 | $1.3M | Form 4 |
| Vitt Daniel | director, officer: CEO and Director | Jul 16, 2025 | AWARD | 860,000 | $0.77 | $662.2K | Form 4 |
| Muehler Andreas | Chief Medical Officer | Jul 16, 2025 | AWARD | 660,000 | $0.77 | $508.2K | Form 4 |
| Muehler Andreas | Chief Medical Officer | Jul 16, 2025 | AWARD | 330,000 | $0.77 | $254.1K | Form 4 |
| Tardio Jason | President and COO | Jul 16, 2025 | AWARD | 660,000 | $0.77 | $508.2K | Form 4 |
| Tardio Jason | President and COO | Jul 16, 2025 | AWARD | 330,000 | $0.77 | $254.1K | Form 4 |
| Tardio Jason | President and COO | Jun 5, 2025 | AWARD | 598,500 | $0.77 | $462.6K | Form 4 |
| Whaley Glenn | Chief Financial Officer | Jun 5, 2025 | AWARD | 503,500 | $0.77 | $389.2K | Form 4 |
| Vitt Daniel | director, officer: CEO and Director | Jun 5, 2025 | AWARD | 1,558,000 | $0.77 | $1.2M | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Jun 5, 2025 | AWARD | 570,000 | $0.77 | $440.6K | Form 4 |
| Muehler Andreas | Chief Medical Officer | Jun 5, 2025 | AWARD | 598,500 | $0.77 | $462.6K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Jun 13, 2025 | BUY | 20,000 | $0.83 | $16.7K | Form 4 |
| HOWSON TAMAR D | director | Jun 5, 2025 | AWARD | 150,000 | $0.77 | $115.9K | Form 4 |
| Skerjanec Simona | director | Jun 5, 2025 | AWARD | 150,000 | $0.77 | $115.9K | Form 4 |
| Rudick Richard Alan | director | Jun 5, 2025 | AWARD | 150,000 | $0.77 | $115.9K | Form 4 |
| Toernsen Monika Maria | director | Jun 5, 2025 | AWARD | 150,000 | $0.77 | $115.9K | Form 4 |
| Tardio Jason | President and COO | Jun 5, 2025 | AWARD | 595,000 | $0.77 | $459.9K | Form 4 |
| Tardio Jason | President and COO | Jun 5, 2025 | BUY | 12,512 | $0.79 | $9.9K | Form 4 |
| Neermann Joerg | director | Jun 5, 2025 | AWARD | 150,000 | $0.77 | $115.9K | Form 4 |
| Whaley Glenn | Chief Financial Officer | Jun 5, 2025 | AWARD | 503,000 | $0.77 | $388.8K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Jun 5, 2025 | AWARD | 560,000 | $0.77 | $432.8K | Form 4 |
| PHILLIPS BARCLAY A | director | Jun 5, 2025 | AWARD | 150,000 | $0.77 | $115.9K | Form 4 |
| Muehler Andreas | Chief Medical Officer | Jun 5, 2025 | AWARD | 595,000 | $0.77 | $459.9K | Form 4 |
| Vitt Daniel | director, officer: CEO and Director | Jun 5, 2025 | AWARD | 1,535,000 | $0.77 | $1.2M | Form 4 |
| Vitt Daniel | director, officer: CEO and Director | Jun 4, 2025 | BUY | 15,000 | $0.77 | $11.6K | Form 4 |
| Neermann Joerg | director | Jun 5, 2025 | BUY | 30,000 | $0.76 | $22.8K | Form 4 |
| Neermann Joerg | director | Jun 4, 2025 | BUY | 70,000 | $0.77 | $53.9K | Form 4 |
| Whaley Glenn | Chief Financial Officer | Jun 3, 2025 | BUY | 45,000 | $0.71 | $32.1K | Form 4 |
| Whaley Glenn | Chief Financial Officer | May 30, 2025 | AWARD | 25,000 | $0.56 | $14.0K | Form 4 |
| Rudick Richard Alan | director | Jun 3, 2025 | BUY | 143,075 | $0.70 | $100.0K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Dec 4, 2024 | AWARD | 300,000 | $1.25 | $375.0K | Form 4 |
| Muehler Andreas | Chief Medical Officer | Dec 4, 2024 | AWARD | 315,000 | $1.25 | $393.8K | Form 4 |
| Tardio Jason | President and COO | Dec 4, 2024 | AWARD | 157,500 | $1.25 | $196.9K | Form 4 |
| Vitt Daniel | director, officer: CEO and Director | Dec 4, 2024 | AWARD | 820,000 | $1.25 | $1.0M | Form 4 |
| Whaley Glenn | Chief Financial Officer | Dec 4, 2024 | AWARD | 265,000 | $1.25 | $331.3K | Form 4 |
| Rudick Richard Alan | director | Nov 12, 2024 | BUY | 87,300 | $1.15 | $100.4K | Form 4 |
| Skerjanec Simona | director | Jul 22, 2024 | AWARD | 100,000 | $1.46 | $146.0K | Form 4 |
| Skerjanec Simona | director | Jul 22, 2024 | AWARD | 50,000 | $1.46 | $73.0K | Form 4 |
| Skerjanec Simona | director: | Jul 22, 2024 | OTHER | 0 | — | — | Form 4 |
| Tardio Jason | President and COO | Jul 12, 2024 | AWARD | 500,000 | $1.25 | $625.0K | Form 4 |
| Tardio Jason | officer | Jul 12, 2024 | OTHER | 0 | — | — | Form 4 |
| Neermann Joerg | director | Jun 11, 2024 | AWARD | 100,000 | $1.27 | $127.0K | Form 4 |
| PHILLIPS BARCLAY A | director | Jun 11, 2024 | AWARD | 100,000 | $1.27 | $127.0K | Form 4 |
| Rudick Richard Alan | director | Jun 11, 2024 | AWARD | 100,000 | $1.27 | $127.0K | Form 4 |
| Toernsen Monika Maria | director | Jun 11, 2024 | AWARD | 100,000 | $1.27 | $127.0K | Form 4 |
| HOWSON TAMAR D | director | Jun 11, 2024 | AWARD | 100,000 | $1.27 | $127.0K | Form 4 |
| HOWSON TAMAR D | director | Mar 4, 2024 | AWARD | 64,959 | $1.72 | $111.7K | Form 4 |
| HOWSON TAMAR D | director | Mar 4, 2024 | DISPOSED | 15,000 | $12.30 | $184.5K | Form 4 |
| HOWSON TAMAR D | director | Mar 4, 2024 | DISPOSED | 9,986 | $9.54 | $95.3K | Form 4 |
| HOWSON TAMAR D | director | Mar 4, 2024 | DISPOSED | 10,000 | $14.77 | $147.7K | Form 4 |
| HOWSON TAMAR D | director | Mar 4, 2024 | DISPOSED | 10,000 | $3.40 | $34.0K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | AWARD | 379,959 | $1.72 | $653.5K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | DISPOSED | 90,000 | $15.44 | $1.4M | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | DISPOSED | 19,973 | $13.63 | $272.2K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | DISPOSED | 120,000 | $17.00 | $2.0M | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | DISPOSED | 75,000 | $10.88 | $816.0K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | DISPOSED | 10,000 | $3.40 | $34.0K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | DISPOSED | 30,000 | $12.30 | $369.0K | Form 4 |
| Nash Duane | director, officer: Executive Chairman | Mar 4, 2024 | DISPOSED | 10,000 | $14.77 | $147.7K | Form 4 |
| PHILLIPS BARCLAY A | director | Mar 4, 2024 | AWARD | 64,959 | $1.72 | $111.7K | Form 4 |
| PHILLIPS BARCLAY A | director | Mar 4, 2024 | DISPOSED | 15,000 | $12.30 | $184.5K | Form 4 |
| PHILLIPS BARCLAY A | director | Mar 4, 2024 | DISPOSED | 10,000 | $3.40 | $34.0K | Form 4 |
| PHILLIPS BARCLAY A | director | Mar 4, 2024 | DISPOSED | 9,986 | $7.63 | $76.2K | Form 4 |
| PHILLIPS BARCLAY A | director | Mar 4, 2024 | DISPOSED | 10,000 | $14.77 | $147.7K | Form 4 |
| Vitt Daniel | director, officer: President and CEO | Mar 4, 2024 | AWARD | 485,000 | $1.72 | $834.2K | Form 4 |